DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
- Quentin Blackford, Executive Vice President and Chief Financial Officer, and Matthew Dolan, Vice President, Corporate Development, will present an update on the company at Morgan Stanley’s 16th Annual Global Healthcare Conference in New York City, NY on Wednesday, September 12, 2018 at 1:05 p.m. (ET). The presentation, which will occur live at the Grand Hyatt Hotel, will be concurrently webcast.
The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180822005165/en/
Contacts
DexCom, Inc.
Steven R. Pacelli, 858-200-0200
Executive Vice President, Strategy and Corporate Development
Source: DexCom, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20180822005165/en
